Pancreatic cancer is the third leading cause of cancer-related deaths, trailing behind lung cancer and colorectal cancer, a ...

Discover GRAIL’s MCED screening tests, Illumina’s divestiture impact, and an $8B valuation base with TAM upside tied to FDA ...

Grail’s stock briefly shot from $78 to $100 on Monday after a weekend report that its blood test had found seven times more cancers than were detectable with standard cancer screens. Now the stock has ...

A three-year clinical trial seeks to find out if a simple blood test can detect cancer in senior citizens. The post Can a ...

Early-stage cancer detection startup Grail, which has investors including Amazon CEO Jeff Bezos, has filed to go public, according to a Sept. 9 CNBC report. 1. DNA-sequencing machine developer ...

CHICAGO -- Hundreds of people using the test company Grail were wrongly told they might have cancer, the company said in a statement Monday. Grail said a software glitch related to their telemedicine ...

MENLO PARK, Calif., Oct. 17, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that positive ...

Galleri Accurately Predicted the Location of the Cancer in Almost All Cases Initially Considered as False Positives, Reinforcing the Value of Galleri's CSO Capability MENLO PARK, Calif. and OXFORD, ...

Samsung C&T and Samsung Electronics Will Make an Equity Investment of $110 Million Into GRAIL, Subject to Closing Conditions "Guided by its commitment to advancing next-generation bio-technologies and ...

What these buzzy new tests can and can't tell you.